AZD0486 (Suvatomib) Shows Strong Efficacy and Safety in Relapsed/Refractory DLBCL丨Professor Maruyama on Latest Clinical Insights
Editor's Note: The global oncology community continues to focus on cutting-edge breakthroughs in lymphoma treatment. At an important academic conference, Professor Maruyama from Keio University Hospital in Tokyo, Japan, presented…








